|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.480 EUR | +2.48% |
|
-7.46% | -1.59% |
| Jan. 20 | BRAIN Biotech AG, 2025 Earnings Call, Jan 14, 2026 | |
| Jan. 14 | BRAIN Biotech AG Provides Revenue Guidance for the Year 2025/2026 | CI |
| Capitalization | 54.18M 63.57M 50.2M 47.21M 87.88M 5.79B 94.27M 579M 229M 2.75B 238M 234M 10.04B | P/E ratio 2026 * |
-7.93x | P/E ratio 2027 * | -34x |
|---|---|---|---|---|---|
| Enterprise value | 78.24M 91.8M 72.49M 68.18M 127M 8.35B 136M 837M 331M 3.97B 344M 337M 14.5B | EV / Sales 2026 * |
1.37x | EV / Sales 2027 * | 1.23x |
| Free-Float |
39.38% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: BRAIN Biotech AG
| 1 day | +2.48% | ||
| 1 week | -7.46% | ||
| Current month | -1.59% | ||
| 1 month | -5.70% | ||
| 3 months | +14.81% | ||
| 6 months | +27.51% | ||
| Current year | -1.59% |
| 1 week | 2.32 |  | 2.56 |
| 1 month | 2.32 | | 2.83 |
| Current year | 2.32 | | 2.83 |
| 1 year | 1.8 | | 3.89 |
| 3 years | 1.42 | | 7.3 |
| 5 years | 1.42 | | 11 |
| 10 years | 1.42 | | 27.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Adriaan Moelker
CEO | Chief Executive Officer | 62 | 2020-01-31 |
| Director of Finance/CFO | 56 | 2022-09-30 | |
Alexander Pelzer
CTO | Chief Tech/Sci/R&D Officer | 40 | 2022-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Majerus
CHM | Chairman | 64 | 2023-03-07 |
Stephen Catling
BRD | Director/Board Member | 61 | 2020-10-13 |
Christine Uekert
BRD | Director/Board Member | 62 | 2023-03-07 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.48% | -7.46% | -25.08% | -59.34% | 61.56M | |
| -0.76% | -5.70% | -62.71% | -84.29% | 200M | |
| +6.64% | +5.90% | +76.30% | -45.92% | 86.94M | |
| +4.82% | +2.96% | +299.08% | +155.88% | 72.71M | |
| Average | +3.30% | -4.29% | +71.90% | -8.42% | 105.4M | |
| Weighted average by Cap. | +2.20% | -4.23% | +33.85% | -31.32% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 56.97M 66.85M 52.79M 49.65M 92.41M 6.08B 99.13M 609M 241M 2.89B 251M 246M 10.56B | 66.57M 78.1M 61.68M 58.01M 108M 7.11B 116M 712M 281M 3.38B 293M 287M 12.33B |
| Net income | -6.81M -7.99M -6.31M -5.93M -11.04M -727M -11.85M -72.82M -28.77M -346M -29.96M -29.34M -1.26B | -1.63M -1.91M -1.51M -1.42M -2.64M -174M -2.83M -17.41M -6.88M -82.67M -7.16M -7.02M -302M |
| Net Debt | 24.06M 28.22M 22.29M 20.96M 39.02M 2.57B 41.85M 257M 102M 1.22B 106M 104M 4.46B | 27.78M 32.59M 25.74M 24.21M 45.06M 2.97B 48.33M 297M 117M 1.41B 122M 120M 5.15B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-01-20 | 2.480 € | +2.48% | 3,834 |
| 26-01-19 | 2.420 € | 0.00% | 3,295 |
| 26-01-16 | 2.420 € | -1.63% | 7,355 |
| 26-01-15 | 2.460 € | +0.82% | 14,709 |
| 26-01-14 | 2.440 € | -9.63% | 33,014 |
Delayed Quote Xetra, January 20, 2026 at 11:35 am EST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Annual profits - Rate of surprise
- Stock Market
- Equities
- BNN Stock
Select your edition
All financial news and data tailored to specific country editions
